CGT Manufacturing

close

Categories

See More

Subscribe to Email Updates

Popular Stories

The Canadian Regulatory System for Cell and Gene Therapies
Viral Aggregation in Downstream Processing of Lentiviral Vectors
Understanding the Role of the Quality Unit in Good Manufacturing Practices
Planning Is Everything - Quality Control Testing in Cell and Gene Therapy
IQ, OQ and PQ: Why Are They Important in the Manufacturing of Cell and Gene Therapies?
10 May 2022

Improved Lentiviral Vector (LVV) Purity with Multi-Modal Chromatography

Our previous post on Considerations for Downstream Processing provides...

09 Jun 2021

Scaling-Up Production of Pluripotent Stem Cells Part 2 – Key Considerations for Successful Scale-Up

In Part 1 of this series we covered some basic definitions and reviewe...

17 Dec 2020

Five Tips to Help Maximize Your Cell and Gene Therapy Budget

Developing cell and gene therapies (CGTs), from discovery to commercia...

11 Dec 2020

4 Tips from the Experts: How to Tighten Your Timeline from Development to Trial

Responsibly moving a cell or gene therapy forward as quickly as possib...

11 May 2020

Viral Aggregation in Downstream Processing of Lentiviral Vectors

Viral vectors are vehicles for delivery of therapeutic DNA in cell and...

24 Oct 2019

What is a Bioreactor and How is it Used in Cell and Gene Therapy?

Simply put, a bioreactor is a stand-alone cell culture vessel enabled ...

05 Sep 2019

What Is the Best Way to Manufacture Lentiviral Vectors for Cell and Gene Therapies?

In the field of cell and gene therapy, there are two main types of vir...

Tell us what you thought about this post.